Planar Hydrogel Microwell Structure for Vascularized Islet Encapsulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing islet transplantation methods face challenges due to poor diffusion-limited transport of nutrients and oxygen, leading to hypoxia and tissue death, exacerbated by the loss of native vasculature and monolithic device structures that hinder new vascular network formation, resulting in limited success and impaired function.
Innovation Solution
A planar biocompatible hydrogel-based macrodevice with a waffle-inspired design featuring interconnected microwells and immuno-isolatory hydrogel components, allowing for controlled spatial distribution of therapeutic microtissues and optional vascular-inductive cells, promoting homogeneous distribution and vascular support.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If encapsulated islets are transplanted into a recipient, then immunological protection is achieved, but diffusion-limited transport of nutrients and oxygen occurs leading to hypoxia and tissue death
Solution Approach 1:
The device is segmented into a modular array of microwells, each capable of holding individual islet clusters. This segmentation increases the surface area to volume ratio and facilitates better nutrient and oxygen diffusion throughout the device compared to a monolithic structure.
Solution Approach 2:
The device utilizes a porous hydrogel matrix that allows for enhanced diffusion of nutrients and oxygen while providing immunological protection. The porous structure maintains structural integrity while enabling efficient mass transport to prevent hypoxia.
2Productivity
If high cell packing density is used to achieve sufficient dosage, then therapeutic correction is improved, but cell aggregation and nonhomogeneous spatial distribution occur leading to limited mass transfer
Solution Approach 1:
The device divides the high cell packing density into multiple discrete microwell compartments, each containing a controlled number of cells. This prevents macroscopic aggregation while maintaining high overall cell density, ensuring homogeneous spatial distribution and adequate mass transfer throughout the device.
Solution Approach 2:
Each microwell is designed with specific local properties (size, shape, porosity) optimized for individual islet cluster containment. This local optimization ensures uniform nutrient distribution and prevents aggregation while maintaining high cell density throughout the device.
3Ease of manufacture
If monolithic device structure is used, then manufacturing is simplified, but new vascular network formation is hindered resulting in poor oxygen and nutrient supply
Solution Approach 1:
The device is fabricated as a segmented array of microwells rather than a monolithic structure. This segmentation creates multiple access points for vascular ingrowth and increases the surface area available for vascular network formation, while still maintaining manufacturing feasibility through standardized microwell fabrication processes.
4Reliability
If native vasculature is lost during transplantation, then encapsulation is achieved, but passive diffusion becomes the main mechanism resulting in poor viability
Solution Approach 1:
The encapsulation device employs a porous hydrogel matrix that facilitates enhanced passive diffusion of nutrients and oxygen compared to dense encapsulation materials. The porous structure maintains encapsulation integrity while minimizing diffusion limitations through its interconnected pore network.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances microtissue viability and function by ensuring uniform nutrient and oxygen supply, supporting angiogenesis, and maintaining cell viability and insulin secretion, thus improving therapeutic efficacy.
Implementation Method 1
poor diffusion-limited transport of nutrients and oxygen
Implementation Method 2
Encapsulating islet grafts in semi-permeable hydrogel membrane
Data Source
AI summary
The present invention generally relates to a therapeutic hydrogel device. More particularly, the present invention describes various embodiments of a hydrogel macrodevice, such as a planar hybrid hydrogel macrodevice that can achieve spatially controlled distribution of microtissues and support establishment of intra-device vasculature for enhanced cell survival, and individually encapsulated microtissues, and methods of use.